SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(RS)-Atenolol | 29122-68-7 | sc-204895 sc-204895A | 1 g 10 g | $77.00 $408.00 | 1 | |
Atenolol, a selective beta-1 adrenergic receptor blocker, affects GPCR signaling indirectly. By blocking beta-1 receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr959 function. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A | 50 mg 500 mg | $68.00 $357.00 | 11 | |
Clozapine, an atypical antipsychotic, acts on various neurotransmitter receptors, including GPCRs. Its broad receptor interaction profile can lead to modulation of GPCR pathways, indirectly affecting Olfr959 activity in olfaction. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $122.00 $235.00 $520.00 $979.00 $1500.00 | 2 | |
Carvedilol, a non-selective beta and alpha-1 adrenergic blocker, affects GPCR signaling indirectly. By blocking these receptors, it can alter G-protein coupling in related GPCRs, potentially impacting Olfr959 function. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $66.00 | 4 | |
(S)-Omeprazole Sodium Salt, a proton pump inhibitor, can indirectly modulate GPCR activity. By influencing gastric acid secretion, it impacts the histamine-mediated modulation of GPCRs, potentially affecting Olfr959 signaling. | ||||||
Labetalol | 36894-69-6 | sc-484723 | 50 mg | $176.00 | ||
Labetalol, a mixed alpha/beta adrenergic antagonist, modulates GPCR signaling pathways. Its action on both alpha and beta receptors can indirectly affect the signaling of GPCRs like Olfr959. | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $73.00 $163.00 | 2 | |
Amlodipine, a calcium channel blocker, can influence GPCR function indirectly. By modulating calcium influx, it affects GPCR-mediated signaling, potentially impacting receptors like Olfr959. | ||||||